| scholarly article | Q13442814 |
| P2093 | author name string | T Satoh | |
| J Wang | |||
| M Watanabe | |||
| G Yang | |||
| A Goltsov | |||
| T C Thompson | |||
| K Tabata | |||
| K Edamura | |||
| D Floryk | |||
| S Kurosaka | |||
| E Abdelfattah | |||
| P2860 | cites work | mRTVP-1, a novel p53 target gene with proapoptotic activities | Q24537301 |
| Cancer statistics, 2010 | Q27860525 | ||
| Alternative activation of macrophages | Q27860939 | ||
| Differential expression of multiple unexpected genes during U937 cell and macrophage differentiation detected by suppressive subtractive hybridization | Q28144048 | ||
| RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer | Q28243964 | ||
| The human glioma pathogenesis-related protein is structurally related to plant pathogenesis-related proteins and its gene is expressed specifically in brain tumors | Q28293164 | ||
| RTVP-1, a novel human gene with sequence similarity to genes of diverse species, is expressed in tumor cell lines of glial but not neuronal origin | Q28299886 | ||
| Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice | Q28509000 | ||
| Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
| Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer | Q29616218 | ||
| Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. | Q30954359 | ||
| PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification | Q33600700 | ||
| Modifications of Adenovirus Hexon Allow for Either Hepatocyte Detargeting or Targeting With Potential Evasion From Kupffer Cells | Q34473365 | ||
| Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. | Q35023644 | ||
| p53 function and dysfunction | Q35721291 | ||
| Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast | Q36618896 | ||
| Gene-modified bone marrow cell therapy for prostate cancer | Q37127252 | ||
| Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer | Q40315007 | ||
| Involvement of inflammatory mediators in macrophage antitumor activity. | Q40782398 | ||
| Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model | Q40937528 | ||
| Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models | Q41220903 | ||
| Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages | Q41337385 | ||
| Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202 | Q41940828 | ||
| Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast. | Q42450606 | ||
| Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection | Q44123726 | ||
| Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus | Q45031707 | ||
| Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses | Q45092359 | ||
| Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer | Q45859014 | ||
| Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling. | Q53325087 | ||
| Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. | Q53516187 | ||
| Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model | Q64377298 | ||
| Differential induction of prostaglandin E2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF | Q72068678 | ||
| Resistance to lysis by cytotoxic T cells: a dominant effect in metastatic mouse prostate cancer cells | Q73679052 | ||
| Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression | Q74248859 | ||
| The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients | Q76380954 | ||
| The p38 mitogen-activated protein kinases can have opposing roles in the antigen-dependent or endotoxin-stimulated production of IL-12 and IFN-gamma | Q77357405 | ||
| Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer | Q78962087 | ||
| Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cells | Q80516707 | ||
| The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase | Q81000005 | ||
| p38 MAPK autophosphorylation drives macrophage IL-12 production during intracellular infection | Q81546534 | ||
| Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes | Q84461047 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 969-978 | |
| P577 | publication date | 2011-04-21 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model | |
| P478 | volume | 18 |
| Q37412075 | Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models |
| Q35795342 | GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells |
| Q38000961 | Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels |
| Q37618071 | Systemic GLIPR1-ΔTM protein as a novel therapeutic approach for prostate cancer |
Search more.